It is reflected in mortality data showing that cardiovascular disease is a leading cause of death in SLE, particularly in patients who survive the first five years after diagnosis
For patients, these ratings translate to better outcomes, fewer complications, improved survival and a smoother recovery after major heart surgery, said Dr
It will also challenge assumptions that many people take for granted
Subscription deliveries can be scheduled every one, two, three, or four months
With seven additional phase 3 readouts expected in 2026, we believe retatrutide could become an important option for patients with significant weight-loss needs and certain complications, including knee osteoarthritis." Conclusion: A New Era in Obesity Treatment The TRIUMPH-4 results represent more than just incremental progressthey signal a paradigm shift in what's possible with pharmacological obesity treatment
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
